APA (7th ed.) Citation

W, M., P, C., A, A., C, V., A, M., A, O., . . . O, A. (2020). Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment. Clinical breast cancer, 20(4), 307. https://doi.org/10.1016/j.clbc.2019.12.011

Chicago Style (17th ed.) Citation

W, Muñoz-Montaño, Cabrera-Galeana P, Alvarado-Miranda A, Villarreal-Garza C, Mohar A, Olvera A, Bargallo-Rocha E, Lara-Medina F, and Arrieta O. "Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment." Clinical Breast Cancer 20, no. 4 (2020): 307. https://doi.org/10.1016/j.clbc.2019.12.011.

MLA (9th ed.) Citation

W, Muñoz-Montaño, et al. "Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment." Clinical Breast Cancer, vol. 20, no. 4, 2020, p. 307, https://doi.org/10.1016/j.clbc.2019.12.011.